Romark Drug Patent Portfolio
Romark owns 1 orange book drug protected by 5 US patents Given below is the list of Romark's drug patents along with their expiration dates.
Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
---|---|---|---|
US5965590 | Method for treatment of opportunistic infections with pharmaceutical compositions of tizoxanide and nitazoxanide | 03 Jul, 2017 | Expired |
US5968961 | Pharmaceutical compositions of tizoxanide and nitazoxanide | 07 May, 2017 | Expired |
US6117894 | Acid stabilized pharmaceutical compositions of tizoxanide and nitazoxanide | 07 May, 2017 | Expired |
US6020353 | 2-(hydroxy)-N-(5-nitro-2-thiazolyl) benzamide | 18 Sep, 2014 | Expired |
US5578621 | Benzamide derivatives | 08 Sep, 2014 | Expired |
Romark's Family Patents
Romark Drug List
Given below is the complete list of Romark's drugs and the patents protecting them.
1. Alinia
Alinia is protected by 7 patents, out of which all have expired. Check out its patent list below.
Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
---|---|---|---|
US5965590 | Method for treatment of opportunistic infections with pharmaceutical compositions of tizoxanide and nitazoxanide |
03 Jul, 2017
(7 years ago)
| Expired |
US5968961 | Pharmaceutical compositions of tizoxanide and nitazoxanide |
07 May, 2017
(7 years ago)
| Expired |
US6117894 | Acid stabilized pharmaceutical compositions of tizoxanide and nitazoxanide |
07 May, 2017
(7 years ago)
| Expired |
US6020353 | 2-(hydroxy)-N-(5-nitro-2-thiazolyl) benzamide |
18 Sep, 2014
(10 years ago)
| Expired |
US5578621 | Benzamide derivatives |
08 Sep, 2014
(10 years ago)
| Expired |
US6020353 | 2-(hydroxy)-N-(5-nitro-2-thiazolyl) benzamide |
08 Sep, 2014
(10 years ago)
| Expired |
US5578621 | Benzamide derivatives |
26 Nov, 2013
(11 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Alinia's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List